Skip to main content
. 2019 Oct 21;25(39):6025–6040. doi: 10.3748/wjg.v25.i39.6025

Figure 5.

Figure 5

Side effect rates between allicin and control groups (intent-to-treat/per-protocol analysis). There was no statistical significance in side effect rates between the allicin group and control group for ITT analysis [5.90% (18/305) vs 9.53% (29/304), odds ratio = 0.61, 95% confidence interval: 0.32-1.16, P = 0.133]. CI: Confidence interval.